Index S&P 500
P/E -
EPS (ttm) -6.74
Insider Own 17.57%
Shs Outstand 863.67M
Perf Week 7.36%
Market Cap 10.20B
Forward P/E 5.87
EPS next Y 2.01
Insider Trans 0.01%
Shs Float 711.58M
Perf Month -24.52%
Income -5811.00M
PEG -
EPS next Q 0.37
Inst Own 59.34%
Short Float 9.58%
Perf Quarter -32.84%
Sales 145.53B
P/S 0.07
EPS this Y -28.33%
Inst Trans -0.06%
Short Ratio 3.76
Perf Half Y -48.85%
Book/sh 15.80
P/B 0.75
EPS next Y -29.37%
ROA -6.40%
Short Interest 68.14M
Perf Year -61.69%
Cash/sh 0.81
P/C 14.51
EPS next 5Y -11.78%
ROE -33.49%
52W Range 10.69 - 31.32
Perf YTD -54.73%
Dividend Est. 1.45 (12.28% )
P/FCF -
EPS past 5Y -
ROI -13.41%
52W High -62.25%
Beta 0.70
Dividend TTM 1.46 (12.35% )
Quick Ratio 0.31
Sales past 5Y 1.35%
Gross Margin 16.70%
52W Low 10.57%
ATR (14) 0.52
Dividend Ex-Date Aug 21, 2024
Current Ratio 0.65
EPS Y/Y TTM -75.58%
Oper. Margin 0.42%
RSI (14) 42.14
Volatility 4.09% 4.32%
Employees 331000
Debt/Eq 2.47
Sales Y/Y TTM 6.92%
Profit Margin -3.99%
Recom 3.05
Target Price 12.57
Option/Short Yes / Yes
LT Debt/Eq 2.18
EPS Q/Q 191.36%
Payout -
Rel Volume 0.80
Prev Close 11.51
Sales Surprise 1.14%
EPS Surprise -7.48%
Sales Q/Q 2.64%
Earnings Jun 27 BMO
Avg Volume 18.12M
Price 11.82
SMA20 3.48%
SMA50 -17.28%
SMA200 -39.77%
Trades
Volume 14,481,274
Change 2.69%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$23
Feb-20-24 Downgrade
HSBC Securities
Hold → Reduce
Jan-03-24 Initiated
Barclays
Underweight
$21
Dec-22-23 Initiated
HSBC Securities
Hold
$27
Oct-23-23 Upgrade
JP Morgan
Neutral → Overweight
$27 → $30
Jul-03-23 Reiterated
Morgan Stanley
Underweight
$37 → $27
Jun-28-23 Downgrade
Deutsche Bank
Buy → Hold
$46 → $34
Feb-23-23 Initiated
Loop Capital
Buy
$45
Nov-23-22 Resumed
Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade
Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade
JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade
Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated
Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade
Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade
Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed
Credit Suisse
Neutral
$42
Apr-06-20 Upgrade
UBS
Sell → Neutral
$49 → $44
Apr-03-20 Upgrade
Deutsche Bank
Sell → Hold
$51 → $43
Show Previous Ratings
Jul-25-24 01:20PM
12:38PM
12:01PM
05:48AM
04:30AM
(Thomson Reuters StreetEvents)
07:15AM
Loading…
Jul-24-24 07:15AM
Jul-23-24 07:00AM
04:42AM
Jul-22-24 08:03AM
Jul-20-24 10:59AM
Jul-18-24 08:00AM
06:00AM
Jul-17-24 05:00PM
12:01PM
06:35AM
10:00AM
Loading…
Jul-16-24 10:00AM
04:51AM
Jul-15-24 11:01AM
10:32AM
08:22AM
Jul-14-24 08:22PM
02:05PM
Jul-13-24 05:05PM
02:42PM
02:42PM
07:10AM
Jul-12-24 07:00AM
Jul-10-24 05:05PM
04:48PM
04:45PM
06:23AM
Loading…
06:23AM
05:30AM
(The Wall Street Journal)
Jul-09-24 09:10PM
07:05PM
01:14PM
06:10AM
Jul-08-24 04:45PM
12:55PM
06:00AM
Jul-07-24 08:00AM
07:10AM
Jul-06-24 07:40AM
Jul-05-24 11:50AM
05:19AM
Jul-04-24 07:33PM
08:37AM
(The Wall Street Journal)
06:46AM
Jul-03-24 04:02PM
Jul-02-24 04:45PM
11:26AM
09:30AM
06:20AM
05:16AM
05:00AM
Jul-01-24 03:16PM
09:22AM
07:59AM
06:40AM
05:41AM
Jun-30-24 05:11AM
04:38AM
03:30AM
Jun-29-24 10:40AM
06:58AM
06:45AM
Jun-28-24 04:30PM
04:26PM
04:18PM
03:54PM
03:29PM
02:15PM
02:15PM
12:46PM
12:17PM
10:01AM
(The Wall Street Journal)
09:57AM
09:42AM
08:20AM
08:03AM
08:03AM
07:00AM
06:49AM
06:46AM
06:00AM
04:03AM
02:14AM
(Thomson Reuters StreetEvents)
01:02AM
Jun-27-24 08:19PM
07:57PM
06:05PM
05:19PM
(The Wall Street Journal)
05:09PM
04:49PM
04:32PM
04:18PM
03:50PM
03:29PM
03:18PM
03:18PM
03:15PM
(Investor's Business Daily)
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM Bhandari Inderpal S Director Apr 11 '24 Buy 18.05 3,000 54,150 3,000 Apr 15 05:45 PM Mahajan Manmohan EVP and Global CFO Apr 02 '24 Buy 19.38 6,000 116,280 166,969 Apr 02 06:40 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 07 '24 Sale 235.41 4,212,395 991,639,907 26,277,561 Feb 09 07:00 AM JARRETT VALERIE B Director Jan 29 '24 Buy 22.44 4,456 99,993 4,456 Jan 31 04:11 PM SCHLICHTING NANCY M Director Jan 16 '24 Sale 23.05 15,209 350,567 0 Jan 18 04:18 PM WENTWORTH TIMOTHY C Chief Executive Officer Jan 05 '24 Buy 24.22 10,000 242,220 585,122 Jan 08 07:29 AM Gates Richard P. SVP, Chief Pharmacy Officer Nov 10 '23 Sale 20.45 1,000 20,450 73,929 Nov 14 08:22 PM Walgreens Boots Alliance, Inc. 10% Owner Nov 09 '23 Sale 195.38 1,279,590 249,999,896 30,489,956 Nov 14 07:15 AM Walgreens Boots Alliance, Inc. 10% Owner Aug 03 '23 Sale 189.27 1,320,858 250,000,115 31,769,546 Aug 07 05:48 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite